Clinical Trial Update: IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study

View source ↗

Summary

A completed prospective pilot study evaluating whether IRD at admission predicts survival in patients with glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: University of Manitoba | Conditions: Glioblastoma Multiforme | Status: COMPLETED